Ryvyl (RVYL) had the highest return between April 1, 2018 and April 30, 2018 by a US stock, returning 342.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Ryvyl (RVYL) | 4/1/2018 - 4/30/2018 | 342.42% |
Reliance Global (RELI) | 4/1/2018 - 4/30/2018 | 339.99% |
Nocera (NCRA) | 4/1/2018 - 4/30/2018 | 214.29% |
Genprex (GNPX) | 4/1/2018 - 4/30/2018 | 212.93% |
Carisma Therapeutics (CARM) | 4/1/2018 - 4/30/2018 | 165.71% |
Turtle Beach (TBCH) | 4/1/2018 - 4/30/2018 | 133.05% |
CleanSpark (CLSK) | 4/1/2018 - 4/30/2018 | 121.67% |
Check-Cap (CHEK) | 4/1/2018 - 4/30/2018 | 105.76% |
Eyepoint Pharmaceuticals (EYPT) | 4/1/2018 - 4/30/2018 | 105% |
OLB (OLB) | 4/1/2018 - 4/30/2018 | 100% |
Creative Medical Technology (CELZ) | 4/1/2018 - 4/30/2018 | 92.91% |
Solid Biosciences LLC (SLDB) | 4/1/2018 - 4/30/2018 | 90.93% |
Data Storage (DTST) | 4/1/2018 - 4/30/2018 | 86.22% |
Tanzanian Royalty Exploration (TRX) | 4/1/2018 - 4/30/2018 | 80.85% |
BTCS (BTCS) | 4/1/2018 - 4/30/2018 | 76.24% |
AGM Group Holdings Inc Class A (AGMH) | 4/1/2018 - 4/30/2018 | 74.55% |
American Battery Technology Company Common Stock (ABAT) | 4/1/2018 - 4/30/2018 | 71.43% |
Immunoprecise Antibodies (IPA) | 4/1/2018 - 4/30/2018 | 70% |
Mawson Infrastructure (MIGI) | 4/1/2018 - 4/30/2018 | 69.43% |
SRx Health Solutions (SRXH) | 4/1/2018 - 4/30/2018 | 66.67% |
Lexaria Bioscience (LEXX) | 4/1/2018 - 4/30/2018 | 64.4% |
Relmada Therapeutics (RLMD) | 4/1/2018 - 4/30/2018 | 64.04% |
Travelzoo (TZOO) | 4/1/2018 - 4/30/2018 | 63.57% |
ZW Data Action Technologies (CNET) | 4/1/2018 - 4/30/2018 | 63.47% |
Baytex Energy (BTE) | 4/1/2018 - 4/30/2018 | 63.14% |
